Literature DB >> 14192522

STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. II. THE EFFECT OF ARTIFICIALLY INDUCED FEVER, NORETHANDROLONE (NILEVAR), AND IOPANOIC ACID (TELAPAQUE).

L J SCHOENFIELD, W T FOULK.   

Abstract

Entities:  

Keywords:  FEVER; IOPANOIC ACID; LIVER FUNCTION TESTS; METABOLISM; NORETHANDROLONE; PHARMACOLOGY; SULFOBROMOPHTHALEIN

Mesh：

Substances：

Year:  1964        PMID： 14192522      PMCID： PMC289617          DOI： 10.1172/JCI105017

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Interference with bilirubin excretion by a gall-bladder dye (bunamiodyl).

Authors:  R J BOLT; R S DILLON; H M POLLARD
Journal:  N Engl J Med       Date:  1961-11-23       Impact factor: 91.245

2.  A liver enzyme that conjugates sulfobromophthalein sodium with glutathione.

Authors:  B COMBES; G S STAKELUM
Journal:  J Clin Invest       Date:  1961-06       Impact factor: 14.808

3.  Observations on norethandrolone-induced abnormalities in plasma decay of sulfobromophthalein and indocvanine green.

Authors:  C M LEEVY; G R CHERRICK; C S DAVIDSON
Journal:  J Lab Clin Med       Date:  1961-06

4.  Cholestasis produced by the administration of norethandrolone.

Authors:  F SCHAFFNER; H POPPER; E CHESROW
Journal:  Am J Med       Date:  1959-02       Impact factor: 4.965

5.  A six-month evaluation of an anabolic drug, norethandrolone, in underweight persons. II. Bromsulphalein (BSP) retention and liver function.

Authors:  R C KORY; M H BRADLEY; R N WATSON; R CALLAHAN; B J PETERS
Journal:  Am J Med       Date:  1959-02       Impact factor: 4.965

6.  Impairment of hepatic bromsulphalein clearance by two 17-substituted testosterones.

Authors:  R P HEANEY; G D WHEDON
Journal:  J Lab Clin Med       Date:  1958-08

7.  THE EFFECT OF SPONTANEOUS AND ARTIFICIALLY INDUCED FEVER ON LIVER FUNCTION.

Authors:  M H Hicks; H P Holt; J L Guerrant; B S Leavell
Journal:  J Clin Invest       Date:  1948-09       Impact factor: 14.808

8.  Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease.

Authors:  H O WHEELER; J I MELTZER; S E BRADLEY
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

9.  STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.

Authors:  L J SCHOENFIELD; W T FOULK; H R BUTT
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

10.  Studies of hepatic excretory function. The effect of 17alpha-ethyl-19-nortestosterone on sulfobromophthalein sodium (BSP) metabolism in man.

Authors:  J SCHERB; M KIRSCHNER; I ARIAS
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808
View more
  5 in total

Review 1.  The nephrogenic hepatic dysfunction syndrome: a review.

Authors:  R C Strickland; S Schenker
Journal:  Am J Dig Dis       Date:  1977-01

2.  [Stauffer's syndrome: reversible hepatic dysfunction in a patient with hypernephroma].

Authors:  J V Souadjian; J Susset; B Longpré; E Lebel; A J Marcoux; R Côté
Journal:  Can Med Assoc J       Date:  1971-08-21       Impact factor: 8.262

3.  Sulphobromophthalein retention in gout and asymptomatic hyperuricaemia.

Authors:  R Grahame; R M Haslam; J T Scott
Journal:  Ann Rheum Dis       Date:  1968-01       Impact factor: 19.103

4.  The effect of sodium taurocholate on the hepatic metabolism of sulfobromophthalein sodium (BSP). The role of bile flow.

Authors:  J L Boyer; R L Scheig; G Klatskin
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

5.  STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.

Authors:  L J SCHOENFIELD; W T FOULK; H R BUTT
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.